Carvedilol Tablets IP 3.125 mg is a specialized pharmaceutical formulation designed exclusively for effective cardiac treatment. Manufactured under stringent WHO-GMP conditions by IndiGlobal Exports, these tablets ensure precision in dosage and reliable therapeutic performance specifically for managing cardiovascular ailments such as hypertension, congestive heart failure, and post-myocardial infarction care. The 3.125 mg dosage offers a low-dose option to initiate or maintain therapy, especially beneficial in titration protocols. Packaged in export-quality blister or strip packs, these tablets are developed in compliance with international pharmacopoeial standards (IP/USP), making them ideal for global pharmaceutical markets requiring strict quality assurance and regulatory adherence. Additionally, each batch undergoes rigorous quality control tests to maintain consistency in active pharmaceutical ingredient concentration, stability, and safety profile. Tailored for hospitals, clinics, and large-scale pharmaceutical distributors, Carvedilol Tablets IP 3.125 mg provides dependable cardioprotective benefits ensuring patient safety through controlled release and bioavailability in tablet form.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Carvedilol 3.125 mg |
| Indication | Management of cardiac conditions such as hypertension and heart failure |
| Dosage Form | Oral Tablet |
| Packaging | Export-grade blister or strip packs |
| Manufacturing Compliance | WHO-GMP certified facility |
| Pharmacopoeial Standards | Indian Pharmacopoeia (IP) / USP compliant |
| Shelf Life | As per regulatory standards |
| Manufacturer | IndiGlobal Exports |
| Suitability | Suitable for regulated and semi-regulated international markets |
| Quality Assurance | Batch tested for dosage consistency and purity |
| Attributes | Description |
|---|---|
| Category | Cardiac Pharmaceutical |
| Formulation Type | Tablet |
| Strength | 3.125 mg |
| Packaging Type | Blister Packs / Strip Packs |
| Dosage Instructions | As prescribed by healthcare professionals |
| Compliance Standards | WHO-GMP, IP/USP |
| Intended Use | Therapeutic management of cardiovascular diseases |
| Stability | Maintains stability and efficacy throughout shelf life |
| Export Suitability | Yes - designed specifically for international pharmaceutical markets |
| Manufacturer Location | IndiGlobal Exports, India |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, these tablets are manufactured in WHO-GMP certified facilities and comply with Indian Pharmacopoeia (IP) and USP standards, ensuring quality and safety suitable for international markets.
The product is available in export-grade blister or strip packs designed to maintain drug stability and ease of bulk shipment for institutional or retail distribution.
Yes, the 3.125 mg strength is ideal for titration purposes in treatment protocols, providing an accurate low-dose option for starting therapy.
Yes, the Carvedilol Tablets IP 3.125 mg are manufactured and packaged to meet or exceed regulatory shelf life standards required in export jurisdictions.
This formulation is primarily indicated for management of hypertension, chronic heart failure, and for improving survival post-myocardial infarction.
Brand: indiglobal exports
Country Of Origin: India
Carvedilol Tablets IP 3.125 mg is a pharmaceutical product indicated for cardiac treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Carvedilol Tablets IP 3.125 mg is developed for the effective management of cardiac conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with cardiac indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
